Abstract:Background Electrical cardioversion (ECV) is routinely used to restore sinus rhythm in patients with symptomatic atrial fibrillation. The European guidelines have been updated in recent years. Current information on differences in the risk for stroke after acute versus elective ECV is lacking. Methods And Results All patients with a first‐time acute or elective ECV in the Stockholm regional health care data warehouse from 2011 to 2018 were included. Cox regression analyses were performed evaluating ischemic or unspecified stroke within 30 days after ECV with adjustments for the CHA 2 DS 2 ‐VASc score, medical treatment, and year of inclusion. The study included 9139 patients, 3094 after acute and 6045 after elective ECV. The mean age was 65.9±11.3 years, 69.5% were men, and the mean CHA 2 DS 2 ‐VASc score was 2.4±1.7. Before the intervention, 49.6% of patients with an acute ECV and 96.4% of those with an elective ECV had claimed an oral anticoagulant prescription. Ischemic or unspecified stroke occurred in 26 (0.28%) patients within 30 days. The unadjusted risk was higher after acute compared with elective ECV (hazard ratio [HR], 2.29; 95% CI, 1.06–4.96), whereas there was no difference after multivariable adjustments (adjusted HR, 0.99; 95% CI, 0.36–2.72). Both non–vitamin K oral anticoagulants (adjusted HR, 0.28; 95% CI, 0.08–0.98) and warfarin (adjusted HR, 0.17; 95% CI, 0.05–0.53) were associated with a lower risk for stroke compared with no anticoagulation. Conclusions Acute ECV was associated with a higher unadjusted risk for stroke than elective ECV, but the risk was similar after adjustment for anticoagulant treatment. This study indicates the importance of anticoagulation before ECV according to recent European guidelines. Nonstandard Abbreviations and Acronyms ECV electrical cardioversion NOAC non–vitamin K oral anticoagulant OAC oral anticoagulant Clinical Perspective What Is New? Electrical cardioversion is a routine procedure both in the acute and elective setup to restore sinus rhythm in patients with symptomatic atrial fibrillation. What Are the Clinical Implications? Risk for stroke is very low after electrical cardioversion when adequate anticoagulation and guideline recommendation follows. Atrial fibrillation (AF) is the most common arrhythmia. Many patients with AF experience disabling symptoms and AF is associated with significant health care consumption including frequent emergency department (ED) visits. 1 Rhythm control therapies like antiarrhythmic drugs and catheter ablation are associated with substantial recurrence rates and not suitable in all patients. 2 Therefore, cardioversion remains an essential tool to restore sinus rhythm in routine AF management. Electrical cardioversion (ECV) is known to be more effective than medical cardioversion for symptomatic AF. Irrespective of the mode, cardioversion is complicated by thromboembolic complications. 3 Thromboembolic risk can be reduced by adequate anticoagulation treatment 4 or transesophageal ultrasound guided exclusion of left atrial thrombus transesophageal echocardiogram before conversion and by continued anticoagulation 4 weeks afterwards. 5 Non–vitamin K antagonist oral anticoagulants (NOACs) have replaced warfarin to a large extent in clinical practice. 6 NOACs have a rapid onset of anticoagulation effect, fewer drug and food interactions 7 and facilitate shorter waiting times to cardioversion than warfarin. 8 In some situations, an emergency cardioversion must be performed in patients with AF who are hemodynamically unstable regardless of prior oral anticoagulant (OAC) treatment. However, in the past decade there has been a shift in the European guidelines on acute ECV for hemodynamic -Abstract Truncated-

Is electrical cardioversion independently associated with infarcts on brain magnetic resonance imaging or clinical outcomes in patients with atrial fibrillation?

Direct synchronized cardioversion not independently associated with infarcts on cerebral magnetic resonance imaging and clinical outcomes in patients with atrial fibrillation

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation.

P1080Magnetic resonance imaging after electrical cardioversion of recent-onset atrial fibrillation in anticoagulant-naive patients - a study exploring clinically silent cerebral lesions

Prediction of the success of electrical cardioversion in patients with atrial fibrillation using parameters obtained by spectral and vectorcardiographic analysis of the ECG

Hospital Utilization and Mortality Post-electrical Cardioversion in Patients With Atrial Fibrillation in a Community Hospital

Primary success of electrical cardioversion for new-onset atrial fibrillation and its association with clinical course in non-cardiac critically ill patients: sub-analysis of a multicenter observational study

Blood pressure, brain lesions and cognitive decline in patients with atrial fibrillation

Influence of Cardioversion on Asymptomatic Cerebral Lesions Following Atrial Fibrillation Ablation.

Electrocardiogram properties and risk of covert brain infarction and other magnetic resonance imaging abnormalities in a stroke‐free population

Prevalence and Distribution of Intracranial Vessel Occlusion on Angiography and Its Association with Functional Outcome in Patients with Atrial Fibrillation Presenting with Ischemic Stroke

The relationship between atrial cardiopathy biomarkers and prognosis of patients with acute ischemic stroke after endovascular treatment

Endovascular therapy in patients with large vessel occlusion due to cardioembolism versus large-artery atherosclerosis

Optimal timing of electrical cardioversion for acute decompensated heart failure caused by atrial arrhythmias: The earlier, the better?

Association of EEG Background With Diffusion-Weighted Magnetic Resonance Neuroimaging and Short-Term Outcomes After Pediatric Cardiac Arrest

Endovascular Treatment of Acute Basilar Artery Occlusion in Patients with and Without Atrial Fibrillation: Results from the ATTENTION Registry

Impact of Defibrillator Electrode Placement on Outcome of Electrical Cardioversion of Atrial Fibrillation: A Pilot Observational Study

Effect of Endovascular Thrombectomy for Acute Ischemic Stroke on Cognitive Outcomes: A Secondary Analysis of the ESCAPE Trial

Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials

Effect of atrial fibrillation on outcomes after mechanical thrombectomy and long-term ischemic recurrence in patients with acute basilar artery occlusion

Brain magnetic resonance imaging and cognitive alterations after ablation in patients with atrial fibrillation